Paul Knight
Stock Analyst at KeyBanc
(3.58)
# 2,224
Out of 4,676 analysts
263
Total ratings
45.3%
Success rate
5.1%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Maintained: Hold | n/a | $4.64 | - | 4 | Aug 6, 2026 | |
| TKNO Alpha Teknova | Maintained: Hold | n/a | $7.46 | - | 5 | Aug 6, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | $350 → $390 | $348.48 | +11.91% | 16 | Jul 2, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $50 → $35 | $35.00 | - | 9 | May 29, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 → $5 | $1.66 | +201.20% | 3 | May 29, 2026 | |
| CYRX Cryoport | Maintained: Buy | $15 → $17 | $16.72 | +1.67% | 10 | May 20, 2026 | |
| TECH Bio-Techne | Maintained: Hold | n/a | $72.33 | - | 19 | May 7, 2026 | |
| XGN Exagen | Maintained: Buy | $15 → $10 | $7.60 | +31.58% | 11 | Mar 11, 2026 | |
| STVN Stevanato Group | Rated: Buy | $37 → $32 | $22.70 | +40.97% | 7 | Mar 5, 2026 | |
| LAB Standard BioTools | Maintained: Hold | n/a | $0.65 | - | 9 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 | $181.69 | +21.09% | 13 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $310 | $215.97 | +43.54% | 9 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $750 | $628.15 | +19.40% | 9 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €415.00 → €320.00 | €246.50 | +29.82% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $37.22 | -11.34% | 10 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $124.84 | +0.13% | 12 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 | $134.72 | +63.30% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | CHF 525.00 | CHF 407.20 | +28.93% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $154.77 | - | 12 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $460 | $414.44 | n/a | 9 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $30 | $14.42 | n/a | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $30 | $7.58 | n/a | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $25.58 | n/a | 2 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $127.35 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 610.00 → CHF 635.00 | CHF 593.80 | n/a | 6 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.00 | n/a | 9 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.21 | n/a | 9 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 | $297.64 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $259.42 | n/a | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.44 | n/a | 6 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.42 | n/a | 1 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $30 | $16.79 | n/a | 3 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.001 | n/a | 8 | Nov 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.98 | n/a | 2 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $44.04 | n/a | 7 | Nov 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $224.99 | n/a | 6 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $56.85 | n/a | 4 | Mar 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.02 | n/a | 2 | Mar 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $50.80 | n/a | 1 | Feb 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $75 → $85 | $230.27 | n/a | 2 | Jul 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $2.27 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $61 → $46 | $11.64 | n/a | 2 | Dec 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $255 | $1,402.25 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $24 | $43.65 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $18 | $0.38499999 | n/a | 1 | Aug 15, 2013 |
Lifecore Biomedical
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $4.64
Upside: -
Alpha Teknova
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $7.46
Upside: -
West Pharmaceutical Services
Jul 2, 2026
Maintained: Buy
Price Target: $350 → $390
Current: $348.48
Upside: +11.91%
Castle Biosciences
May 29, 2026
Maintained: Buy
Price Target: $50 → $35
Current: $35.00
Upside: -
Rapid Micro Biosystems
May 29, 2026
Maintained: Buy
Price Target: $8 → $5
Current: $1.66
Upside: +201.20%
Cryoport
May 20, 2026
Maintained: Buy
Price Target: $15 → $17
Current: $16.72
Upside: +1.67%
Bio-Techne
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $72.33
Upside: -
Exagen
Mar 11, 2026
Maintained: Buy
Price Target: $15 → $10
Current: $7.60
Upside: +31.58%
Stevanato Group
Mar 5, 2026
Rated: Buy
Price Target: $37 → $32
Current: $22.70
Upside: +40.97%
Standard BioTools
Feb 25, 2026
Maintained: Hold
Price Target: n/a
Current: $0.65
Upside: -
Feb 25, 2026
Maintained: Buy
Price Target: $220
Current: $181.69
Upside: +21.09%
Dec 18, 2025
Rated: Buy
Price Target: $310
Current: $215.97
Upside: +43.54%
Dec 8, 2025
Upgraded: Buy
Price Target: $750
Current: $628.15
Upside: +19.40%
Oct 7, 2025
Maintained: Buy
Price Target: €415.00 → €320.00
Current: €246.50
Upside: +29.82%
Oct 3, 2025
Maintained: Buy
Price Target: $33
Current: $37.22
Upside: -11.34%
Sep 16, 2025
Maintained: Buy
Price Target: $125
Current: $124.84
Upside: +0.13%
Sep 10, 2025
Maintained: Buy
Price Target: $220
Current: $134.72
Upside: +63.30%
Sep 4, 2025
Initiated Coverage: Buy
Price Target: CHF 525.00
Current: CHF 407.20
Upside: +28.93%
Aug 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $154.77
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $460
Current: $414.44
Upside: n/a
Jun 3, 2025
Reiterated: Buy
Price Target: $40 → $30
Current: $14.42
Upside: n/a
Apr 9, 2025
Downgraded: Hold
Price Target: $7 → $30
Current: $7.58
Upside: n/a
Mar 31, 2025
Downgraded: Hold
Price Target: n/a
Current: $25.58
Upside: n/a
Feb 5, 2025
Reiterated: Hold
Price Target: n/a
Current: $127.35
Upside: n/a
Jan 30, 2025
Maintained: Buy
Price Target: CHF 610.00 → CHF 635.00
Current: CHF 593.80
Upside: n/a
May 9, 2024
Rated: Hold
Price Target: n/a
Current: $9.00
Upside: n/a
Nov 14, 2023
Rated: Hold
Price Target: n/a
Current: $33.21
Upside: n/a
May 5, 2022
Maintained: Buy
Price Target: $300
Current: $297.64
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $250
Current: $259.42
Upside: n/a
Mar 14, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.44
Upside: n/a
Apr 15, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $1.42
Upside: n/a
Feb 27, 2020
Maintained: Hold
Price Target: $20 → $30
Current: $16.79
Upside: n/a
Nov 26, 2019
Downgraded: Hold
Price Target: $6 → $2
Current: $0.001
Upside: n/a
Jul 24, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.98
Upside: n/a
Nov 29, 2018
Downgraded: Hold
Price Target: n/a
Current: $44.04
Upside: n/a
Oct 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $224.99
Upside: n/a
Mar 27, 2017
Downgraded: Hold
Price Target: n/a
Current: $56.85
Upside: n/a
Mar 11, 2016
Downgraded: Hold
Price Target: n/a
Current: $1.02
Upside: n/a
Feb 10, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $50.80
Upside: n/a
Jul 24, 2014
Downgraded: Hold
Price Target: $75 → $85
Current: $230.27
Upside: n/a
May 5, 2014
Upgraded: Buy
Price Target: n/a
Current: $2.27
Upside: n/a
Dec 19, 2013
Rated: Hold
Price Target: $61 → $46
Current: $11.64
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $255
Current: $1,402.25
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $24
Current: $43.65
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $18
Current: $0.38499999
Upside: n/a